Haya S - Search Results

1

Querol F, Aznar JA, Haya S, Cid A. Querol F, et al. Among authors: haya s. Haemophilia. 2002 May;8(3):407-12. doi: 10.1046/j.1365-2516.2002.00637.x. Haemophilia. 2002. PMID: 12010442 Review.

2

Predictive factors of immune tolerance treatment response in severe haemophilia A patients with inhibitors: A real-world report from a single centre, mixed retrospective-prospective long-term study.

Haya S, Solano C, Cid AR, Argilés B, Hervás D, Querol F, Bonanad S, Casaña P. Haya S, et al. Haemophilia. 2019 Mar;25(2):e97-e100. doi: 10.1111/hae.13660. Epub 2019 Jan 3. Haemophilia. 2019. PMID: 30604912 Free PMC article. No abstract available.

3

Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate^® ) and BAY 81-8973 (Kovaltry^® ) in patients with severe or moderate haemophilia A in prophylaxis.

Megías-Vericat JE, Bonanad S, Haya S, Cid AR, Marqués MR, Monte-Boquet E, Pérez-Alenda S, Bosch P, Querol F, Poveda JL. Megías-Vericat JE, et al. Among authors: haya s. Haemophilia. 2019 May;25(3):e215-e218. doi: 10.1111/hae.13733. Epub 2019 Mar 13. Haemophilia. 2019. PMID: 30866068 No abstract available.

4

Zero incidence of inhibitor development in previously treated haemophilia A, HIV-negative patients upon exposure to a plasma-derived high-purity and double viral inactivated factor VIII concentrate.

Aznar JA, Lorenzo JI, Molina R, Haya S, Querol F, Dasí MA. Aznar JA, et al. Among authors: haya s. Haemophilia. 1998 Jan;4(1):21-4. doi: 10.1046/j.1365-2516.1998.00139.x. Haemophilia. 1998. PMID: 9873861

5

Development of a factor VIII inhibitor in a newborn haemophiliac.

Haya S, Lorenzo JI, Dasí MA, Aznar JA. Haya S, et al. Haemophilia. 1998 Sep;4(5):755-6. doi: 10.1046/j.1365-2516.1998.00178.x. Haemophilia. 1998. PMID: 9873883

6

A comparison of FVII:C and FVIIa assays for the monitoring of recombinant factor VIIa treatment.

Cid AR, Lorenzo JI, Haya S, Montoro JM, Casaña P, Aznar JA. Cid AR, et al. Among authors: haya s. Haemophilia. 2001 Jan;7(1):39-41. doi: 10.1046/j.1365-2516.2001.00478.x. Haemophilia. 2001. PMID: 11136379

7

Immune tolerance treatment in haemophilia patients with inhibitors: the Spanish Registry.

Haya S, López MF, Aznar JA, Batlle J; Spanish Immune Tolerance Group. Haya S, et al. Haemophilia. 2001 Mar;7(2):154-9. doi: 10.1046/j.1365-2516.2001.00469.x. Haemophilia. 2001. PMID: 11260274

8

Inhibitor development in one patient and laboratory discrepancies in several families with both mild haemophilia and Arg531Cys mutation.

Cid AR, Casaña P, Cabrera N, Haya S, Cortina V, Aznar JA. Cid AR, et al. Among authors: haya s. Haemophilia. 2007 Mar;13(2):206-8. doi: 10.1111/j.1365-2516.2006.01422.x. Haemophilia. 2007. PMID: 17286776

9

Inhibitors in haemophilia A: current management and open issues.

Haya S, Moret A, Cid AR, Cortina V, Casaña P, Cabrera N, Aznar JA. Haya S, et al. Haemophilia. 2007 Dec;13 Suppl 5:52-60. doi: 10.1111/j.1365-2516.2007.01574.x. Haemophilia. 2007. PMID: 18078398 Review.

10

One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype.

Cid AR, Calabuig M, Cortina V, Casaña P, Haya S, Moret A, Cabrera N, Aznar JA. Cid AR, et al. Among authors: haya s. Haemophilia. 2008 Sep;14(5):1049-54. doi: 10.1111/j.1365-2516.2008.01781.x. Epub 2008 Jun 5. Haemophilia. 2008. PMID: 18540892

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters